According to authorities, a Bay Area doctor spent more than $ 270,000 on overseas branded products that she resold over four years as Botox and Juvederm in treatments valued at more than $ 1 million.

In an indictment by the federal grand jury that was unsealed on Friday, Dr. Lindsay Marie Clark accused of receiving mislabeled and unapproved drugs and devices from early 2016 to early 2020 and making them available to her patients.

Clark, who lives and practices in San Francisco and in San Mateo, urged her staff to hide the true identity of the products from her patients. That emerges from a statement released late Friday by acting U.S. attorney Stephanie M. Hinds, the lead federal agency, prosecutor for the Northern District of California.

Botox, made from botulinum toxin, is marketed as a remedy for sagging and wrinkled skin. Juvederm made from hyaluronic acid is advertised as a dermal filler.

Both products are class III medical devices. That means they are regulated due to the risk of disease or injury they pose if things go wrong, such as pacemakers and breast implants, according to the US Food and Drug Administration website.

Lisa L. Malinowski, special agent in Los Angeles, said in the US attorney’s statement that the distribution of “prescription drugs and devices of unknown origin puts the health of … patients at significant risk.”

If Clark is convicted of the crimes filed earlier this month, he could be sentenced to three years in prison and fined $ 10,000.

Any action by the Medical Board of California that regulates the licensing of doctors to practice would be segregated from the criminal matter.

Clark, who appeared in court in San Francisco on Friday, is on bail, according to prosecutors.

Bay Area NewsCrimePeninsulasan Francisco News

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Learn more at